INNOVADERM-RESEARCH
Innovaderm Honoured With a CRO Leadership Award Again This Year
Innovaderm is the proud recipient of a 2022 CRO Leadership Award after garnering outstanding support in the Quality and Reliability categories. This is the second consecutive win for the high-achieving dermatology CRO.
“We are very pleased to have been selected once again by our sponsors for this prestigious award and laud our team for their extraordinary work this past year,” says Dr. Robert Bissonnette, Innovaderm’s founder and Chief Executive Officer. “As a leader in therapeutic dermatology, we pride ourselves on the delivery of quality services while driving research forward.”
Presented by Clinical Leader, Life Science Leader, and Industry Standard Research, the CRO Leadership Awards recognize top clinical trial service partners based on feedback from sponsor pharmaceutical and biopharmaceutical companies that outsource clinical trials. This year, 50 contract research organizations were assessed on over 20 performance metrics.
“Innovaderm has a reputation of excellence in clinical research in dermatology,” says Dave Selkirk, Innovaderm’s Chief Operating Officer,“ and this leadership award is a testament to our success in the field.”
To learn about Innovaderm’s services, visit our website .
Innovaderm Research Inc.
Innovaderm Research Inc. is a global, full-service CRO specialized in therapeutic dermatology. Founded in 2000, it partners with biotechnology companies for the collaborative management of early to late phase clinical trials. Its mission is to drive innovative research initiatives and offer new therapies for patients living with skin disease.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005138/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MA-ANTERRA-CAPITAL18.5.2022 07:02:06 CEST | Press release
Anterra Capital: Pandemic and Food Price Inflation Fuel Investor Interest to Accelerate Transformation of the Food and Ag Sector
CONVIVA18.5.2022 03:02:10 CEST | Press release
US Streaming Technology Giant Conviva Launches Full-Scale Continuous Measurement Analytics in Japan
NY-STARR/FPG17.5.2022 22:35:13 CEST | Press release
Starr Insurance Companies Expands in Thailand
NY-EMENDO-BIO17.5.2022 22:17:09 CEST | Press release
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
MN-PIPER-SANDLER17.5.2022 20:01:06 CEST | Press release
Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom